Industry Symposium 33

30 Mar 2026 8:10 a.m. 9:10 a.m.
304
JunOh Chair Germany

Session Title:  Chronic Kidney Disease in Children: Challenges of Diagnosis, Screening, and Management

Organized By: Boehringer Ingelheim GmbH

Session Description: 

Chronic kidney disease (CKD) in children has a significant impact on morbidity, mortality, and quality of life, in addition to effects on growth and neurocognitive development. There are significant differences in the underlying etiology and prevalence of CKD in children compared with adults. Furthermore, diagnosis and screening are complicated by age-specific changes in glomerular filtration rate.
 
In this session, an international faculty of expert nephrologists will outline the key challenges facing clinicians when screening, diagnosing and treating children with chronic kidney disease, and will describe approaches for clinical trials in this patient population.

Learning Objectives :

1. Attendees will have a greater understanding of the unmet needs in screening, diagnosing and treating chronic kidney disease in pediatric patients

2. Attendees will understand the challenges in designing a clinical trial in this patient population
Time Session
8:10 a.m.
8:15 a.m.
Welcome and introduction
JunOh Speaker j.oh@uke.deGermany
8:15 a.m.
8:25 a.m.
The burden of pediatric chronic kidney disease: Epidemiology, etiology and unmet needs
KenjiIshikura Speaker lxkenzo@gmail.comJapan
8:25 a.m.
8:35 a.m.
Studying pediatric chronic kidney disease: Challenges in evidence generation and clinical research
HughMcCarthy Speaker hugh.mccarthy@health.nsw.gov.auAustralia
8:35 a.m.
8:55 a.m.
The long-term consequences of childhood CKD: Growth, cardiovascular risk and adult outcomes
JunOh Speaker j.oh@uke.deGermany
8:55 a.m.
9 a.m.
Summary
JunOh Speaker j.oh@uke.deGermany
9 a.m.
9:10 a.m.
Discussion and Q&A